DUBLIN--(BUSINESS WIRE)--The new research portal will provide visitors with unparalleled access to company research on NanoBio Corporation, alongside comprehensive market research on their position within the global pharmaceutical industry.
NanoBio is a featured company in the Global Influenza Market report. This report is designed to be a helpful business tool that provides a thorough evaluation of the market for influenza vaccines, therapeutics and diagnostics. It provides information about products available, products in development, issues and trends influencing the market, and competitive analysis of top providers, with a special emphasis on U.S. and European markets.
According to the report, the market is expected to increase from $5.4 Billion in 2016 to $6.4 billion in 2021 at a CAGR of 3.6%.
“NanoBio is a leading player within the global influenza market and the new portal provides easy access to information on their performance as a company and their impact on the overall pharma industry,” says Ross Glover, CEO of Research and Markets.
For more information visit: http://www.researchandmarkets.com/companies/nanobio-corporation?cid=gf7zqk
About Research and Markets
Research and Markets is the world's leading market research store.
With more than 1.5 million research resources, we deliver the largest collection of business information products on the market. We offer the most in-depth market analysis across a multitude of industries. Our products provide clients with an unrivalled understanding of their chosen market. No matter how specialist your field, we have the insights and market data to help you make efficient and effective decisions.